参考文献/References:
[1] 中国医师协会介入医师分会. 中国肝细胞癌经动脉化疗栓塞治疗(TACE)临床实践指南[J]. 介入放射学杂志, 2018, 27:1117-1126.
[2] Thayer D, Noda C, Charalel R, et al. Survival comparison of hepatocellular carcinoma patients treated with radioembolization versus nonoperative/interventional treatment[J]. J Comp Eff Res, 2018, 7:343-356.
[3] 崔 鹏, 杜小丽, 周 瀚, 等. TACE治疗肝癌伴门脉癌栓患者的预后分析[J]. 介入放射学杂志, 2018, 27: 266-271.
[4] Lü N, Kong Y, Mu L. Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoem-bolization for inoperable hepatocellular carcinoma:a prospective randomized trail[J]. Eur Radiol, 2016, 26: 3492-3499.
[5] Fatma M, Faiyaz F, Mohamed A. Eliminating the use of intravenous glass bottles using a FOCUS-PDCA model and providing a practical stability reference guide[J]. Int J Pharm Pract, 2016, 24: 271- 282.
[6] Davies AN,Dickman A,Reid C, et al. The management of cancer-related breakthrough pain:recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland[J]. Eur J Pain, 2009, 13:331-338.
[7] 李爱丽. FOCUS-PDCA持续质量改进模式对脑梗死后偏瘫患者的影响[J]. 齐鲁护理杂志, 2018, 24: 24-27.
[8] 柴剑丽, 吴春燕, 王文娟. 糖尿病肾病患者血液透析中低血糖管理的持续质量改进[J]. 中华护理杂志, 2015, 50: 170-174.
[9] 覃丽锦, 黄丽群, 韦永鲜. 绩效考核与FOCUS-PDCA程序化结合在专科护士培训中的应用[J]. 护士进修杂志, 2018, 33: 68-70.
[10] 杨建娣, 朱林贞, 杨超娟. 内镜中心应用FOCUS-PDCA模式提高软式内镜消毒质量的研究[J]. 中华医院感染学杂志, 2017,27: 4252-4254.
相似文献/References:
[1]王建新,许成平,邵亚男,等. 125Ⅰ-LUF体毛导向治疗晚期肝癌初步报告[J].介入放射学杂志,1997,(01):16.
[2]龚承友,初曙光,陈陵际,等.蓖麻蛋白对裸鼠肝癌瘤体内注射的疗效及骨髓抑制的研究[J].介入放射学杂志,1997,(04):219.
[3]马广勤,高从敬,万向荣,等.晚期肝癌变异性、寄生性供血的基础研究[J].介入放射学杂志,1998,(02):95.
[4]刘传方,詹迎江.外生型肝癌三例[J].介入放射学杂志,1998,(03):190.
[5]程红岩,曲增强,徐爱民,等.肝癌介入治疗中预防副反应的初步探讨[J].介入放射学杂志,1998,(03):161.
[6]黄小明,于淼,暴军玲,等.甲氧氯普胺治疗肝癌介入治疗中的胃肠道反应[J].介入放射学杂志,1998,(04):245.
[7]张桂敏,陆翠玉.肝癌介入治疗术后物品的消毒处理[J].介入放射学杂志,1998,(04):244.
[8]杨熙章,吴纪瑞,杨永岩,等.灌注化疗预防肝癌术后复发[J].介入放射学杂志,1999,(02):32.
[9]钟力,夏海平,王吉先,等.肝动脉栓塞化疗结合超声导向注射酒精治疗肝癌的疗效观察[J].介入放射学杂志,1992,(01):48.
[10]李章钧.晚期肝梅毒误为肝癌一例[J].介入放射学杂志,1993,(01):4.